| PanretinŽ | |
| Brand Name: | PanretinŽ |
| Active Ingredient: | alitretinoin |
| Strength(s): | 0.1% |
| Dosage Form(s): | Topical gel |
| Company Name: | Ligand Pharmaceuticals |
| Availability: | Prescription only |
| *Date Approved by the FDA: | February 2, 1999 |
| *Approval by FDA does not mean that the drug is
ss of drugs to which Panretin gel belongs (retinoids) increase in the
skin’s sensitivity to sunlight and sunlamps. Expose skin areas being treated with
Panretin gel to sunlight and sunlamps as little as possible.
When you are being treated with Panretin gel, do not use products that contain DEET, a common ingredient of insect repellents because Panretin gel increases the toxicity of DEET. What are some possible side effects of Panretin gel? (This is NOT a complete list of side effects reported with Panretin gel. Your health care provider can discuss with you a more complete list of side effects.) Side effects with the use of Panretin gel occur mainly at the site where it is applied. If side effects occur, they are usually mild to moderate, although severe adverse reactions occur in 10% of patients using Panretin gel. Side effects may be lowered with a decrease in the frequency of application; if you experience side effects, contact your health care provider. Some other possible side effects can include:
For more detailed information about Panretin gel, ask your health care provider. Link to
Panretin Gel's Label and patient informaiton Posted 4/6/99 |
|
